These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 43885)

  • 1. Complexes of technetium with pyrophosphate, etidronate, and medronate.
    Russell CD; Cash AG
    J Nucl Med; 1979 Jun; 20(6):532-7. PubMed ID: 43885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexes of technetium with hydroxycarboxylic acids: gluconic, glucoheptonic, tartaric, and citric.
    Russell CD; Speiser AG
    J Nucl Med; 1980 Nov; 21(11):1086-90. PubMed ID: 7431109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo behaviour of four different 99(m)Tc-HEDP complexes.
    Inoue O; Yamaguchi T; Ikeda I
    Nuklearmedizin; 1982 Dec; 21(6):227-31. PubMed ID: 6820139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
    J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
    Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oxygen on the reduction of pertechnetate by stannous ion.
    Owunwanne A; Church LB; Blau M
    J Nucl Med; 1977 Aug; 18(8):822-6. PubMed ID: 874171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium pyrophosphate: a mixture?--Preparation of Tc(III) and Tc(IV) pyrophosphates and their comparative biologic properties.
    Russell CD; Majerik JE; Cash AG; Lindsay RH
    Int J Nucl Med Biol; 1978; 5(4-5):190-5. PubMed ID: 217848
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolution of technetium speciation in reducing grout.
    Lukens WW; Bucher JI; Shuh DK; Edelstein NM
    Environ Sci Technol; 2005 Oct; 39(20):8064-70. PubMed ID: 16295876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication.
    Silberstein EB; Maxon HR; Alexander GW; Rauf C; Bahr GK
    J Nucl Med; 1978 Feb; 19(2):161-3. PubMed ID: 203665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of technetium and its speciation by surface-enhanced Raman spectroscopy.
    Gu B; Ruan C
    Anal Chem; 2007 Mar; 79(6):2341-5. PubMed ID: 17288465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decomposition of Tc-99m pyrophosphate by peroxides in pertechnetate used in preparation.
    Der M; Ballinger JR; Bowen BM
    J Nucl Med; 1981 Jul; 22(7):645-6. PubMed ID: 6265608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 19. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
    Rudd TG; Allen DR; Hartnett DE
    J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of technetium etidronate and pyrophosphate for acute myocardial infarct imaging.
    Williams CC; Nishiyama H; Adolph RJ; Romhilt DW; Sodd VJ; Saenger EL; Gabel M
    J Nucl Med; 1977 Sep; 18(9):905-9. PubMed ID: 197134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.